You have 9 free searches left this month | for more free features.

Leukemia, B-Cell

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Large B Cell Lymphoma Relapsed, Diffuse Large B Cell Lymphoma Refractory Trial in United States (Ibrutinib, DA-EPOCH-R,

Completed
  • Diffuse Large B Cell Lymphoma Relapsed
  • Diffuse Large B Cell Lymphoma Refractory
  • Duarte, California
  • +9 more
Jan 14, 2019

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Pulmonary Artery-First Surgical Technique
  • Biospecimen Collection
  • (no location specified)
Aug 15, 2022

NSCLC Trial in Worldwide (Lazertinib 240 mg/160 mg, Gefitinib 250 mg, Lazertinib-matching 240 mg/160 mg)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Lazertinib 240 mg/160 mg
  • +3 more
  • Woolloongabba, Queensland, Australia
  • +79 more
Nov 1, 2022

GI Motility Disorder Trial in Leuven (Corticotropin-release hormone)

Recruiting
  • GI Motility Disorder
  • Corticotropin-release hormone
  • Leuven, Belgium
    I-Hsuan Huang
Oct 7, 2021

Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)

Recruiting
  • Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022

Immunological Follow-up of Patients With Basedow's Orbitopathy

Completed
  • Graves Orbitopathy
    • Montpellier, France
      Uhmontpellier
    Jan 10, 2022

    Kidney Failure, Chronic, Chronic Kidney Disease stage3, Chronic Kidney Disease Stage 3B Trial in Lyon (Low-AGE diet, High-AGE

    Not yet recruiting
    • Kidney Failure, Chronic
    • +5 more
    • Low-AGE diet
    • High-AGE diet
    • Lyon, France
      Centre Hospitalier Saint Joseph Saint Luc
    Jan 3, 2022

    Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial (Defibrotide)

    Not yet recruiting
    • Sinusoidal Obstruction Syndrome
    • Veno-occlusive Disease
    • (no location specified)
    Aug 4, 2023

    Lung Cancer Trial in Toulouse (Blood samples will be collected at two times before the treatment initiation:)

    Not yet recruiting
    • Lung Cancer
    • Blood samples will be collected at two times before the treatment initiation:
    • Toulouse, France
    • +1 more
    Aug 3, 2023

    Tumors, NUT Carcinoma Trial in Worldwide (BI 894999)

    Completed
    • Neoplasms
    • NUT Carcinoma
    • BI 894999
    • Boston, Massachusetts
    • +15 more
    Dec 3, 2021

    Prostate Cancer Trial in Kelowna (Low dose rate prostate brachytherapy, High Dose Rate prostate brachytherapy)

    Recruiting
    • Prostate Cancer
    • Low dose rate prostate brachytherapy
    • High Dose Rate prostate brachytherapy
    • Kelowna, British Columbia, Canada
      British Columbia Cancer Agency Center for the Southern Interior
    Mar 3, 2022

    Acute Myeloid Leukemia Leukemia Trial in Shanghai (MRX2843)

    Not yet recruiting
    • Acute Myeloid Leukemia Leukemia
    • Shanghai, Shanghai, China
      Junmin Li,Ph.D
    Jun 23, 2021

    Spinal Cord Injuries Trial in Amman (Collection and expansion of BM-MSC, VI-SCI evaluation and patients' follow up)

    Completed
    • Spinal Cord Injuries
    • Collection and expansion of BM-MSC
    • VI-SCI evaluation and patients' follow up
    • Amman, Jordan
      Cell Therapy Center, University of Jordan
    Aug 24, 2021

    Hemophilia B Trial (VGB-R04)

    Not yet recruiting
    • Hemophilia B
    • VGB-R04
    • (no location specified)
    Nov 29, 2021

    Hepatitis B Virus Infection Trial in Changsha (Standard antiviral therapy)

    Recruiting
    • Hepatitis B Virus Infection
    • Standard antiviral therapy
    • Changsha, Hunan, China
      Department of Infectious Disease, Xiangya Hospital, Central Sout
    May 22, 2022

    DVT of Legs Trial in Hvidovre (Blood sample and Ultrasound examination)

    Recruiting
    • DVT of Legs
    • Blood sample and Ultrasound examination
    • Hvidovre, Copenhagen, Denmark
      Copenhagen University Hospital Hvidovre
    Mar 15, 2023

    Patients With Chronic Hepatitis B (CHB) Infection

    Recruiting
    • Hepatitis B
    • +2 more
    • All approved therapies for the treatment of Chronic Hepatitis B (CHB)
    • Phoenix, Arizona
    • +30 more
    Jan 27, 2023

    Immunologic Deficiency Syndromes Trial in Milano (Strimvelis)

    Enrolling by invitation
    • Immunologic Deficiency Syndromes
    • Strimvelis
    • Milano, Lombardia, Italy
      Orchard Investigational Site
    Jun 23, 2021

    Study of Transfusion-Transmitted Infections

    Completed
    • Viral Disease
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Bladder Cancer, Urothelial Carcinoma Bladder Trial in Mumbai (Adjuvant RT)

      Recruiting
      • Bladder Cancer
      • Urothelial Carcinoma Bladder
      • Adjuvant RT
      • Mumbai, Maharashtra, India
        Tata Memorial Centre
      Oct 6, 2021

      Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))

      Not yet recruiting
      • Oral Cavity Squamous Cell Carcinoma
      • NisinZ® P
      • Surgery (non-interventional, standard of care)
      • San Francisco, California
        University of California, San Francisco
      Oct 18, 2023

      Migraine Trial in New York (PMR (Progressive muscle relaxation therapy), Monitored Usual Care (MUC))

      Completed
      • Migraine
      • PMR (Progressive muscle relaxation therapy)
      • Monitored Usual Care (MUC)
      • New York, New York
        NYU Langone
      Sep 20, 2022

      GVHD Trial in New Brunswick (Lactobacillus rhamnosus GG, laboratory biomarker analysis was not performed because of no

      Completed
      • Graft Versus Host Disease
      • Lactobacillus rhamnosus GG
      • laboratory biomarker analysis was not performed because of no differences in the clinical outcomes
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Apr 23, 2021

      NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC), NSCLC (NSCLC) Trial (Birabresib)

      Terminated
      • NUT Midline Carcinoma (NMC)
      • +3 more
      • (no location specified)
      Jan 7, 2021